Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2021-06-25 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated June 25, 2021, addressed to stock exchanges, informing them about the schedule of an Analyst/Institutional Investor meeting via conference call. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is an announcement of a meeting schedule rather than a report or transcript of the meeting. It does not contain financial data, detailed presentation, or results. Therefore, it fits the category of an Investor Presentation announcement or meeting schedule. However, since it is only an intimation of the schedule and not the presentation itself, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other categories.
2021-06-25 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a detailed disclosure of related party transactions for the half year ended March 31, 2021, including names of key managerial personnel, relatives, and other related parties, along with transaction details such as compensation, sitting fees, commissions, and dividends. It references compliance under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 23(9), which mandates disclosure of related party transactions. The content is focused on related party transactions and disclosures rather than a full financial report or earnings release. It is not a brief announcement or a certification letter but a substantive disclosure document. Such disclosures typically fall under Regulatory Filings (RNS) as they are compliance-related announcements that do not constitute full financial reports or management discussions. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-06-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document contains a table listing a meeting date, the name of an analyst/institutional investor, the venue, and the type of meeting, which is a 'One on One Conference Call'. There is no substantive financial data, no detailed report content, and the document length is very short (438 characters). This suggests it is not a full earnings release or financial report but rather a record or announcement related to a conference call. Given the nature of the content, it aligns best with a Call Transcript (CT) or a meeting notice related to a call. However, since there is no transcript text but only meeting details, it is more likely a Call Transcript category as it relates to conference calls. Confidence is high due to clear meeting and call references.
2021-06-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the schedule of an upcoming analyst/institutional investor meeting, specifically a conference call on June 14, 2021. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of a meeting schedule rather than a transcript or detailed report. The document length is only 1238 characters, indicating it is a brief notice rather than a full report or transcript. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-06-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a short notice dated June 9, 2021, addressed to stock exchanges, informing them about the schedule of an upcoming analyst/institutional investor meeting (conference call) on June 10, 2021. It explicitly states it is pursuant to SEBI regulations and provides details of the meeting date, type, and venue. There is no financial data, no report attached or referenced, and no detailed transcript or presentation included. This is a typical announcement of an investor meeting or conference call schedule, not the call transcript itself or any financial report. Therefore, the document fits best under the category of Investor Presentation (IP) or possibly a Regulatory Filing (RNS). However, since it is specifically about scheduling an analyst/investor meeting (conference call), the best fit is Investor Presentation (IP) as it relates to investor communications and meetings. Confidence is high given the clear content and purpose.
2021-06-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of a financial results conference call for Q4 and FY21 of Dr. Lal PathLabs Limited. It includes management speeches, financial highlights, and Q&A session details. The text explicitly mentions it is a "Financial Results Conference Call Transcript" and contains detailed discussion of quarterly and full-year financial performance, operational updates, and management commentary. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls with Q&A. The document length is substantial (15,000 characters), and it contains the full transcript, not just an announcement or summary. Therefore, the correct classification is CT with high confidence.
2021-06-08 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.